title: Complications of endovascular treatment for acute stroke in the SWIFT trial with solitaire and Merci devices.
abstract: OBJECTIVE
  Treatment of patients with ischemic stroke after endovascular treatment requires in-depth knowledge of complications. The goal of this study was to make endovascular treatment for acute ischemic stroke safer through an in-depth review of the major periprocedural complications observed in the Solitaire FR With Intention for Thrombectomy (SWIFT) trial.
  
  
  METHODS
  The SWIFT data base was searched for major peri-procedural complications defined as symptomatic intracranial hemorrhage within 36 hours, SAH, air emboli, vessel dissection, major groin complications, and emboli to new vascular territories.
  
  
  RESULTS
  Major peri-procedural complications occurred in 18 of 144 patients (12.5%) as follows: symptomatic intracranial hemorrhage, 4.9%; air emboli, 1.4%; vessel dissection, 4.2%; major groin complications, 2.8%; and emboli to new vascular territories, 0.7%. Rates of symptomatic intracranial bleeding by subtype were PH1, 0.7%; PH2, 0.7% (PH1 indicates hematoma within ischemic field with some mild space-occupying effect but involving ≤ 30% of the infarcted area; PH2, hematoma within ischemic field with space-occupying effect involving >30% of the infarcted area); intracranial hemorrhage remote from ischemic zone, 0%; intraventricular hemorrhage, 0.7%; and SAH, 3.5%. We did not observe any statistically significant associations of peri-procedural complications with age; type of treatment center; duration of stroke symptoms; NIHSS score, IV thrombolytics, atrial fibrillation, site of vessel occlusion; rescue therapy administered after endovascular treatment; or device. Comparing the Merci with the Solitaire FR retrieval device, we observed symptomatic cerebral hemorrhage (10.9% versus 1.1%; P = .013); symptomatic SAH (7.3% versus 1.1%; P = .07), air emboli (1.8% versus 1.1%; P = 1.0), emboli to new vascular territories (1.8% versus 0%; P = .38), vessel dissection (1.8% versus 4.5%; P = .65), and major groin complications (3.6% versus 7.9%; P = .48). Angiographic vasospasm was common but without clinical sequelae.
  
  
  CONCLUSIONS
  Understanding of procedural complications is important for treatment of patients with stroke after endovascular treatment. We observed fewer endovascular complications with the Solitaire FR device treatment compared with Merci device treatment, particularly symptomatic cerebral hemorrhage.
authors.affiliation: From the Department of Neurosurgery (P.T.A.), Kaiser Permanente, Sacramento, California.
authors.forename: P T
authors.initials: PT
authors.lastname: Akins
authors.forename: A P
authors.initials: AP
authors.lastname: Amar
authors.forename: R S
authors.initials: RS
authors.lastname: Pakbaz
authors.forename: J D
authors.initials: JD
authors.lastname: Fields
mesh_terms: D000328:Adult; D000368:Aged; D057510:Endovascular Procedures / Q000009:adverse effects* / Q000295:instrumentation*; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D011446:Prospective Studies; D020521:Stroke / Q000601:surgery*; D017131:Thrombectomy; D055815:Young Adult
references.citation: JAMA. 1995 Oct 4;274(13):1017-25
references.pmid: 7563451
references.citation: Stroke. 2008 Apr;39(4):1205-12
references.pmid: 18309168
references.citation: AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1078-81
references.pmid: 21493763
references.citation: Stroke. 2008 Dec;39(12):3283-7
references.pmid: 18772441
references.citation: World Neurosurg. 2011 Dec;76(6 Suppl):S16-23
references.pmid: 22182267
references.citation: Stroke. 2005 Jul;36(7):1432-8
references.pmid: 15961709
references.citation: JAMA. 1999 Dec 1;282(21):2003-11
references.pmid: 10591382
references.citation: Stroke. 1998 Jan;29(1):4-11
references.pmid: 9445320
references.citation: AJNR Am J Neuroradiol. 2008 Aug;29(7):1409-13
references.pmid: 18499798
references.citation: N Engl J Med. 2013 Mar 7;368(10):893-903
references.pmid: 23390923
references.citation: Neurosurg Clin N Am. 1992 Jul;3(3):601-10
references.pmid: 1633483
references.citation: Stroke. 2004 Apr;35(4):904-11
references.pmid: 15017018
references.citation: N Engl J Med. 1985 Apr 4;312(14):932-6
references.pmid: 4038784
references.citation: Stroke. 2010 Dec;41(12):2775-81
references.pmid: 21051673
references.citation: Lancet. 2012 Oct 6;380(9849):1241-9
references.pmid: 22932715
references.citation: Stroke. 2007 Jul;38(7):2127-35
references.pmid: 17525387
references.citation: J Neurointerv Surg. 2012 Jan 1;4(1):62-6
references.pmid: 21990438
references.citation: N Engl J Med. 1995 Dec 14;333(24):1581-7
references.pmid: 7477192
references.citation: Stroke. 2007 Mar;38(3):967-73
references.pmid: 17272772